U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Criminal Investigations
  4. Press Releases
  5. Former Nurse Pleads Guilty to Drug Diversion from Two Boston-Area Hospitals
  1. Press Releases

Former Nurse Pleads Guilty to Drug Diversion from Two Boston-Area Hospitals

OCI Badge

Department of Justice
District of Massachusetts 

FOR IMMEDIATE RELEASE
Tuesday, October 4, 2022

BOSTON – A former nurse pleaded guilty yesterday in federal court in Boston to diverting opioids from two Boston-area hospitals.

Lisa Tarr, 33, of St. Petersburg, Fla., pleaded guilty to four counts of unlawfully obtaining controlled substances by fraud, deception and subterfuge. U.S. Senior District Court Judge Douglas P. Woodlock scheduled sentencing for Feb. 7, 2023. Tarr was charged by an Information on Sept. 12, 2022.

In August 2018, Tarr was a Student Nurse working at a Boston-area hospital. Tarr admitted to investigators at the hospital that she had stolen and self-injected fentanyl, a Schedule II controlled substance, from the hospital.

In 2020, while working for another Boston-area hospital, Tarr stole an infusion bag containing fentanyl that was being used to treat a patient. On another occasion in 2020, while still working at the second hospital, Tarr stole multiple syringes of hydromorphone, a Schedule II controlled substance, from a locked drug cabinet.

The charge of unlawfully obtaining controlled substances by fraud provides a sentence of no greater than four years in prison, one year of supervised release and a fine of up to $250,000. Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case.

United States Attorney Rachael S. Rollins; Fernando McMillan, Special Agent in Charge of the Food and Drug Administration, Office of Criminal Investigations, New York Field Office; and Margret Cooke, the Commissioner of the Massachusetts Department of Public Health made the announcement. Assistant U.S. Attorney Kelly Begg Lawrence, Chief of Rollins’ Health Care Fraud Unit, and Assistant U.S. Attorney Evan Panich of Rollins’ Narcotics & Money Laundering Unit are prosecuting the case.

Topic(s): 
Prescription Drugs

Component(s): 
USAO - Massachusetts
 

Back to Top